drugset / Trial / NCT00035542

A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.

NCT00035542

Phase 3 Completed Bristol-Myers Squibb
Treatment

Summary

The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.

Timeline

Start
2001-12
Primary completion
2003-10
Completion
2003-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucovance Unknown
Subject Glyburide Small molecule
Subject Metformin Small molecule